Target Name: ZNF570
NCBI ID: G148268
Review Report on ZNF570 Target / Biomarker Content of Review Report on ZNF570 Target / Biomarker
ZNF570
Other Name(s): ZN570_HUMAN | Zinc finger protein 570, transcript variant 2 | Zinc finger protein 570 | Zinc finger protein 570 (isoform 2) | zinc finger protein 570 | ZNF570 variant 2

Regulation of Neural Development and Function By ZNF570

ZNF570 (ZN570_HUMAN), a protein encoded by the ZNF5 gene, is a key regulator of neural development and function. The ZNF5 gene is located on chromosome 6 (6p) and has been implicated in the development and progression of various neurological disorders, including neurodegenerative diseases. ZNF570 has been shown to play a crucial role in the regulation of neuronal excitability and synaptic plasticity, and is potential drug target for a variety of neurological conditions.

The ZNF5 gene is part of a family of transcription factors that are known as ZNF transcription factors. These transcription factors are known for their ability to regulate gene expression and are involved in the regulation of various cellular processes, including cell growth, differentiation, and survival . The ZNF5 gene is unique in that it has four functional domains: a N-terminal domain that contains a leucine-rich repeat, a transmembrane domain that contains aa hydrophobic region, and a C-terminal domain that contains a cullin-3- like domain and a leucine-rich repeat.

The ZNF5 gene was first identified in mouse using transcriptional assays that were designed to identify ZNF5-containing RNA molecules. The ZNF5 RNA was shown to be highly expressed in various tissues and cellular types, including brain, spinal cord, and neural stem/progenitor cells . ZNF5 RNA was also shown to be involved in the regulation of neuronal excitability and synaptic plasticity, as well as in the development and progression of various neurological disorders.

In addition to its role in neuronal excitability and synaptic plasticity, ZNF5 has also been shown to play a crucial role in the regulation of neuronal survival. Studies have shown that ZNF5 is involved in the regulation of neurogenesis, and that its expression is directly linked to the survival of neuronal cells. ZNF5 has also been shown to play a role in the regulation of neuroinflammation, and that its expression is associated with the development of neuroinflammation-related diseases.

Given the unique role that ZNF5 plays in the regulation of neural development and function, it is a promising target for drug development for a variety of neurological conditions. Studies have shown that various small molecules and drug candidates have the potential to modulate ZNF5 activity and improve neuronal function in a variety of neurological conditions, including neurodegenerative diseases. For example, small molecules such as E134, a Ascafloxacin and curcumin, a natural compound found in turmeric, have been shown to modulate ZNF5 activity and improve neuronal function in neurodegenerative diseases.

In conclusion, ZNF570 (ZN570_HUMAN) is a protein that has the potential to be a drug target for a variety of neurological conditions. Its unique role in the regulation of neural development and function, as well as its involvement in the regulation of neuronal survival and neuroinflammation, make it an attractive target for drug development. Further research is needed to fully understand the role of ZNF570 in the regulation of neural development and function, as well as its potential as a drug target.

Protein Name: Zinc Finger Protein 570

Functions: May be involved in transcriptional regulation

The "ZNF570 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF570 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF571 | ZNF571-AS1 | ZNF572 | ZNF573 | ZNF574 | ZNF575 | ZNF576 | ZNF577 | ZNF578 | ZNF579 | ZNF580 | ZNF582 | ZNF582-DT | ZNF583 | ZNF584 | ZNF585A | ZNF585B | ZNF586 | ZNF587 | ZNF587B | ZNF589 | ZNF592 | ZNF593 | ZNF594 | ZNF594-DT | ZNF595 | ZNF596 | ZNF597 | ZNF598 | ZNF599 | ZNF600 | ZNF603P | ZNF605 | ZNF606 | ZNF607 | ZNF608 | ZNF609 | ZNF610 | ZNF611 | ZNF613 | ZNF614 | ZNF615 | ZNF616 | ZNF618 | ZNF619 | ZNF620 | ZNF621 | ZNF622 | ZNF623 | ZNF624 | ZNF625 | ZNF625-ZNF20 | ZNF626 | ZNF627 | ZNF628 | ZNF629 | ZNF630 | ZNF638 | ZNF639 | ZNF641 | ZNF644 | ZNF646 | ZNF648 | ZNF649 | ZNF652 | ZNF652-AS1 | ZNF653 | ZNF654 | ZNF655 | ZNF658 | ZNF658B | ZNF66 | ZNF660 | ZNF662 | ZNF663P | ZNF664 | ZNF664-RFLNA | ZNF665 | ZNF667 | ZNF667-AS1 | ZNF668 | ZNF669 | ZNF670 | ZNF670-ZNF695 | ZNF671 | ZNF672 | ZNF674 | ZNF674-AS1 | ZNF675 | ZNF676 | ZNF677 | ZNF678 | ZNF679 | ZNF680 | ZNF681 | ZNF682 | ZNF683 | ZNF684 | ZNF687 | ZNF688